Returning for its 11th year, the IMPACCT: Real World Evidence Summit 2023 will deep dive into the use of RWE for regulatory submissions and clinical trial innovation to unlock unstructured […]

Biosensors for Medical Wearables Conference and Expo *In collaboration with Medical Design Briefs* October 23-24, 2023 | Boston, MA, USA http://www.biosensors-medical-wear.com/PharmaJournalist-WL SAE Media Group’s 3rd Annual Biosensors for Medical Wearables […]

CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products. As this paradigm takes place, more complex CRISPR structures […]

Accelerating More Transformative Gene Therapies for CNS Disorders Despite a challenging 2022 for Gene Therapy developers targeting the CNS, the recent approvals of Skysona by bluebird bio and Upstaza by PTC Therapeutics have validated the potential that gene […]

Join us at this year's much-anticipated Extractables and Leachables Europe, taking place on 6-7 November 2023 in Amsterdam. This year's conference promises to once again provide you with everything you […]

PURIFY – Chromatography Purification Conclave PURIFY Conclaves are pioneers of dedicated conferences in India that will help stretch possibilities, be it discovery, development or scaleups! The pharmaceutical industry continues to […]

The 7th Microbiome Movement – Human Nutrition Summit will unite 100+ human nutrition leaders this November in Livingston, NJ to optimize product development and consumer acceptance of microbiome-based food and […]

Behind regulatory milestones like the recent accelerated FDA approval for Duchenne Muscular Dystrophy, robust and detailed analytics are the cornerstone of gene therapy development. As regulators scrutinize products more closely, […]

Eli Lilly’s ‘triple G’ drug retatrutide has galvanized the metabolic field to boost investment in the game-changing obesity drug revolution. With up to 24% weight loss, a new record for […]

Enter the inaugural Cell Therapy for Autoimmune Disease Summit, a pioneering platform singularly focused on uniting and empowering this community for the first time. Experts will delve into cutting-edge frontiers […]

The Donor Selection & Cell Source Summit is your ultimate platform to explore the latest global regulatory requirements and differences on donor testing, understand the novel genome sequencing data being used to […]

CRISPR represents the next frontier in the cell and gene therapy landscape. Spearheaded by the first gene edited therapeutic awaiting FDA approval, a mounting wave of innovative technology developments and […]

The Advanced Purification for Complex Biologics Summit is the first and only standalone conference focused on purification for biologics and novel modalities bringing together purification, CMC and MSAT professionals to […]

The 3rd ADC Target Selection Summit (December 5-7 | Boston, MA). This is the ultimate cover-to-cover conference providing insights to help you optimize the pairing of target, antibody, and linker-payload […]

Enzyme Engineering Enabling Scalable Industrial Biotransformation for Sustainable API Production In 2023, an era of advanced enzyme engineering technology is rapidly enabling the generation of game-changing enzymes for novel transformations. As […]

Bringing the covalency field under one roof for the first time, the inaugural Covalent Drug Discovery Summit comes to Boston this December – gathering 80+ covalent drug specialists from the likes of […]

200+ Attendees | 33+ World-Class Speakers | 23+ Data Driven Case Studies Returning to Boston this December for its 6th year, the RNA-Targeted Drug Discovery & Development Summit is the only […]

The Health Economics & Outcomes Research Summit is a focused intimate gathering of HEOR professionals, moving past basic introductions to advanced tactical and strategic conversations best leveraging innovative methods to demonstrate […]

Following recent struggles in the industry, the leading annual 8th Oncolytic Virotherapy Summit returns to Boston, MA in December (12-14), as the industry’s definitive, and most comprehensive forum. Bringing you 29+ world-class […]

The inaugural Gene Therapy Process Development Summit is a must-attend to discover the latest insights to bridge the gap between R&D and process development, ensuring that high-quality gene therapies are […]

SAE Media Group's 16th Annual Pre-Filled Syringes and Injectable Drug Devices Conference will return to London in January 2024 to unite leaders from the industry and bring you the latest […]

With 2023 welcoming newly FDA-approved gene therapies from BioMarin, Krystal Biotech and Sarepta Therapeutics, many more treatments are hot on their heels for approval, investment is pouring into developing gene […]

250+ mRNA Specialists | 40+ World-Class Speakers | 2 Streams of Content The 3rd mRNA-Based Therapeutics Summit Europe returns to Berlin this 23rd-25th January to unite European biopharma, to hear from the […]

The 2nd Annual Next Generation Ophthalmic Drug Delivery Summit is returning to San Francisco this January to unite 90+ device engineers, biochemists, preclinical and clinical experts as they discuss how they are optimizing longer-lasting and […]

As Europe’s premiere microbiome conference tightly focused on the development of microbiome-based therapeutics, this is your prime opportunity to expand your microbiome-based drug development capabilities and business potential as we […]

As we witness a surge in later-stage clinical trials within the gene therapy industry, the spotlight on comparability has never been brighter. That's why we're thrilled to announce the return […]

100+ Technical mRNA Specialists | 35+ Expert Speakers As access to faster and higher-throughput analytical methods becomes increasingly vital, it is critical that we employ superior analytical approaches for mRNA-based […]

The 6th Annual CRISPR AgBio Congress is back on February 20-22, 2024 (Raleigh, NC). The dedicated congress that unites industry stakeholders across Agbiotech, big seed, distributors, and investors, to assess […]

Viral Vector Process Development & Manufacturing Summit Create Qualitative, Accessible Treatments for Patients Following Ring Therapeutics’ injection of $86.5m to enhance novel viral vector capabilities, and BMS’s viral vector facility […]

From Bristol Myers Squibb expanding their cardiovascular partnership with Avidity Biosciences' antibody-oligonucleotide conjugate technology, to Nurix and Seagen collaborating on a targeted protein degradation conjugate, there is now a staggering amount of investment and collaboration in the novel […]